Sept. 30, 2025 — Biograph and Caristo Diagnostics have announced a partnership for Biograph to become the first U.S ...
Sept. 29, 2025 — Many studies have shown the inverse relationship between bone mineral density (BMD) — the gold standard ...
Sept. 30, 2025 — Cleerly has announced that coverage policies from UnitedHealthcare and Cigna for Cleerly LABS advanced ...
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
Sept. 29, 2025 — Radiation therapy may offer a comparable and potentially safer alternative to repeat catheter ablation ...
Sept. 29, 2025 — AngioSafe has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its ...
Sept. 25, 2025 — Royal Philips has entered a national partnership in the United States with Optum Healthcare. The ...
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
Sept. 25, 2025 — Kardigan has introduced the three late-stage clinical programs leading its robust pipeline, each ...
Sept. 24, 2025 — The Family Heart Foundation, a leading research and advocacy organization, has announced the online ...
Sept. 23, 2025 — Ultromics, a pioneer in AI-driven cardiology solutions, has announced findings from its new study on ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
Sept. 22, 2025 — Nicklaus Children's Heart Institute in Miami, Florida, is now offering bedside transcatheter patent ...
Sept. 23, 2025 — CeleCor Therapeutics’ multinational Phase 3 clinical trial of its investigational heart-attack drug ...
Sept. 22, 2025 — Heartflow, Inc. has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Next Gen ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
Sept. 22, 2025 — The latest findings on heart failure (HF) published by the Heart Failure Society of America (HFSA) ...
Sept. 18, 2025 — The Society of Nuclear Medicine and Molecular Imaging (SNMMI), American Society of Nuclear Cardiology ...
Sept. 18, 2025 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for treating cardiovascular and ...
October 02, 2025
